Company Profile

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA)
7:52 PM EDT, 08/21/19
Last: $7.45 Change: +0.44 %Change: +6.28% Volume: 26,068,359
Detailed Quote
Open: $ 7.21   Volume: 26,068,359
High: $ 7.53   Yield(%) n/a
Low: $ 7.05   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 7.66B
EPS ($) n/a   Shares Out: 1.09B
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -8.72
% Price Change (last 13 weeks): -40.89
% Price Change (last 26 weeks): -61.10
% Price Change (last 52 weeks): -72.15
% Price Change (year to date): -55.77
Management Effectiveness
Return on Equity (%): -13.37
Return on Assets (%): -3.26
Return on Invested Capital (%): -3.91
Profitability
Gross Profit Margin (%): 44.00
Net Profit Margin (%): -11.40
Operating Profit Margin (%): 15.22
Price & Volume
50-day Moving Average: $8.08
200-day Moving Average: $14.57
Avg. Daily Vol. (last 50 days): 20,533,502
Avg. Daily Vol. (last 200 days): 14,801,414
52-wk high: $25.13
52-wk low: $6.07
Bid: $7.30
Ask: $7.55
Company Information
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company, which engages in development, production and marketing of drugs, generic drugs, over-the-counter drugs, active ingredients for the pharmaceutical industry (APIs) and therapeutic products. It operates through two segments: Generic Medicines and Specialty Medicines. The Generic Medicines segment includes chemical and therapeutic equivalents of originator medicines in a variety of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams. The Specialty Medicine segment engages in the provision of core therapeutic areas of central nervous system medicines. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.
Teva Pharmaceutical Industries Ltd.
5 Basel Street
Petach Tikva HM 49131

Phone: 972.3.926.7267
Fax: 972.3.923.4050
http://www.tevapharm.com
Per Share Data
Earnings (1year) ($): -3.83
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 13.49
Cash Flow ($): -0.51
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): 0.84
Price/Book (x): 1.14
Price/Cash Flow (x): 3.78
Financial Strength
Quick Ratio (x): 0.63
Current Ratio (x): 0.96
LT Debt/Equity (x): 181.55
Total Debt/Equity (x): 196.61



Quotes displayed with 15 minutes delay. Market data provided by ICE Data Services ICE Limitations. Powered and implemented by FactSet. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Hemscott equity data provided by Morningstar, Inc. Earnings Calendar and Events Data provided by Wall Street Horizon. © 2018 Wall Street Horizon, Inc.